Adlai Nortye ANL
NASDAQ ANL
$15.01 +0.26 (+1.76%)
At close: Sep 4, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Retained Earnings (2022 - 2026)

Adlai Nortye (ANL) posted quarterly Retained Earnings of -$464.8 million for Q4 2025, down 8.28% year-over-year from -$506.8 million in Q4 2024, and down 3.84% quarter-over-quarter from -$447.7 million in Q2 2025.

Analysis

Adlai Nortye (ANL) Retained Earnings (2022 - 2026) Analysis & Trends

Adlai Nortye (ANL) has reported Retained Earnings for 4 consecutive years, with -$464.8 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Retained Earnings fell 8.28% year-over-year to -$464.8 million; the TTM figure through Dec 2025 stood at -$464.8 million (down 8.28% YoY), while the FY2025 annual figure was -$464.8 million, down 8.28% from the prior year.
  • Retained Earnings eased to -$464.8 million in Q4 2025 per ANL's latest filing, from -$447.7 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $6.4 million in Q4 2022 and bottomed at -$464.8 million in Q4 2025.
  • Historically, Retained Earnings has averaged -$288.6 million across 4 years, with a median of -$415.0 million in 2024.
  • Annual changes were most pronounced in 2024 — Retained Earnings tumbled 9857.23% — and 2025, when it fell 8.28%.
  • Adlai Nortye's Retained Earnings stood at $6.4 million in 2022, then tumbled by 31.41% to $4.4 million in 2023, then sank by 9857.23% to -$429.3 million in 2024, then dropped by 8.28% to -$464.8 million in 2025.
  • Business Quant data shows ANL's Retained Earnings at -$464.8 million in Q4 2025, -$447.7 million in Q2 2025, and -$429.3 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Adlai Nortye 500.08 Mn 268.19 Mn - -470.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -470.18 Mn
Dec 31, 2025 -464.85 Mn
Jun 30, 2025 -447.65 Mn
Dec 31, 2024 -429.32 Mn
Jun 30, 2024 -400.70 Mn
Dec 31, 2023 4.40 Mn
Dec 31, 2022 -268.22 Mn